CLNN Clene Inc.

$6.00 +1.10%

Healthcare · Pharmaceutical Preparations

Clene Inc. (CLNN) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $77 million. Shares last traded at $6.00, 54.9% below their 52-week high. Over the past year the stock is up 39.3%. Net profit margin is -13086.5%, below the peer median of -0.1%. Revenue declined 41.5% year over year.

Market Cap

$77M

Shares Out

12.8M

EPS (TTM)

$-1.68

P/E Ratio

—

P/S Ratio

383.03

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$13.29

52-Week Low

$3.28

Volume

541

Avg Vol (3m)

11,957.905

Performance

+8.41%

-9.17%

-2.52%

-8.33%

YTD

+3.01%

+39.26%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

48.97

SMA (50)

$6.33

SMA (200)

$6.57

Price vs SMA50

-5.25%

Price vs SMA200

-8.74%

ATR (14)

$0.39

Financials

Revenue

$0M

Net Income

$-26M

Gross Margin

—

Operating Margin

-11541.5%

Net Margin

-13086.5%

Return on Equity

139.2%

Return on Assets

-120.8%

Current Ratio

1.94

Debt / Equity

-0.94

Revenue Growth (YoY)

-41.5%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q3 2022	$-0.46	2022-11-07
Q2 2022	$-0.28	2022-08-15
Q3 2022	$-0.23	2022-11-07
Q2 2022	$-0.71	2022-08-15
Q3 2021	$-1.16	2021-11-08

Full earnings history →

Pharmaceutical Preparations peers

CLNN vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

383.03 / 3.54 med

+10727% premium

Net margin vs peers

-13086.5% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.